Document is current
Any future updates will be listed below
-
Authors
Stahl-Gugger, Alenka
de Godoi Rezende Costa Molino, Caroline
Wieczorek, Maud
Chocano-Bedoya, Patricia O.
Abderhalden, Lauren A.
Schaer, Dominik J.
Spahn, Donat R.
Orav, E. John
Vellas, Bruno
da Silva, José A. P.
Kressig, Reto W.
Egli, Andreas
Bischoff-Ferrari, Heike A. http://orcid.org/0000-0002-4554-658X
,
Bischoff-Ferrari, Heike A.
Egli, Andreas
Vellas, Bruno
Guyonnet, Sophie
Rizzoli, René
Biver, Emmanuel
Merminod, Fanny
Kressig, Reto W.
Bridenbaugh, Stephanie
Suhm, Norbert
Silva, José A. P.
Duarte, Cátia C. M.
Felsenberg, Dieter
Börst, Hendrikje
Armbrecht, Gabriele
Blauth, Michael
Spicher, Anna
Felson, David T.
Kanis, John A.
Mccloskey, Eugene V.
Johansson, Elena
Watzl, Bernhard
Hofbauer, Lorenz
Tsourdi, Elena
Rauner, Martina
Siebert, Uwe
Kanis, John A.
Ferrari, Stephen M.
Gut, Benno
Ba, Marième
Etheve, Stéphane
Eggersdorfer, Manfred
Reuschling, Monika
Orav, Endel J.
Willett, Walter C.
Manson, JoAnn E.
Dawson-Hughes, Bess
Staehelin, Hannes B.
Walter, Paul W.
Dick, Walter
Fried, Michael
Eckardstein, Arnold
Theiler, Robert
Simmen, Hans-Peter
Langhans, Wolfgang
Zinkernagel, Annelies
Mueller, Nicolas
Distler, Oliver
Graetz, Klaus
Nitschke, Ina
Dietrich, Thomas
Baer, Walter
Landau, Klara
Ruschitzka, Frank
Manz, Markus
Burckhardt, Peter
-
Funding
Funding for this research was provided by:
Vifor Pharma (independent, investigator-initiated grant)
European Commission (EC-GA № 278588)
University of Zurich (Chair for Geriatric Medicine, Aging Research)
DSM nutritional products
Roche diagnostics
Nestec
Pfizer Consumer Healthcare
STREULI Pharma
University of Zurich
- License Information
-
More Information
Article History
Received: 23 November 2021
Accepted: 3 February 2022
First Online: 18 March 2022
Declarations
:
: HABF received as the PI of this study independent and investigator-initiated funding by Vifor Pharma. LAA is currently an employee of MSD, Switzerland. DRS’s academic department is receiving grant support from the Swiss National Science Foundation, Berne, Switzerland, the Swiss Society of Anesthesiology and Reanimation (SGAR), Berne, Switzerland, the Swiss Foundation for Anesthesia Research, Zurich, Switzerland, Vifor SA, Villars-sur-Glâne, Switzerland and Vifor (International) AG, St. Gallen, Switzerland. DRS is co-chair of the ABC-Trauma Faculty, sponsored by unrestricted educational grants from Novo Nordisk Health Care AG, Zurich, Switzerland, CSL Behring GmbH, Marburg, Germany, LFB Biomédicaments, Courtaboeuf Cedex, France and Octapharma AG, Lachen, Switzerland. DRS received honoraria / travel support for consulting or lecturing from: Danube University of Krems, Austria, US Department of Defense, Washington, USA, European Society of Anesthesiology, Brussels, BE, Korean Society for Patient Blood Management, Seoul, Korea, Korean Society of Anesthesiologists, Seoul, Korea, Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis, Paris, France, Alexion Pharmaceuticals Inc., Boston, MA, Baxalta Switzerland AG, Volketswil, Switzerland, Bayer AG, Zürich, Switzerland, B. Braun Melsungen AG, Melsungen, Germany, Boehringer Ingelheim GmbH, Basel, Switzerland, Bristol-Myers-Squibb, Rueil-Malmaison Cedex, France and Baar, Switzerland, CSL Behring GmbH, Hattersheim am Main, Germany and Berne, Switzerland, Celgene International II Sàrl, Couvet, Switzerland, Daiichi Sankyo AG, Thalwil, Switzerland, Haemonetics, Braintree, MA, USA, Instrumentation Laboratory (Werfen), Bedford, MA, USA, LFB Biomédicaments, Courtaboeuf Cedex, France, Merck Sharp & Dohme, Kenilworth, New Jersey, USA, Novo Nordisk Health Care AG, Zurich, Switzerland, PAION Deutschland GmbH, Aachen, Germany, Pharmacosmos A/S, Holbaek, Denmark, Pfizer AG, Zürich, Switzerland, Pierre Fabre Pharma, Alschwil, Switzerland, Portola Schweiz GmbH, Aarau, Switzerland, Roche Diagnostics International Ltd, Reinach, Switzerland, Sarstedt AG & Co., Sevelen, Switzerland and Nümbrecht, Germany, Shire Switzerland GmbH, Zug, Switzerland, Tem International GmbH, Munich, Germany, Vifor Pharma, Munich, Germany, Neuilly sur Seine, France and Villars-sur-Glâne, Switzerland, Vifor (International) AG, St. Gallen, Switzerland, Zuellig Pharma Holdings, Singapore, Singapore.
: The Cantonal Ethical Committee of the Canton of Zurich approved this ancillary analysis (BASEC N° 2018–01755).
: Informed consent was obtained from all individual participants included in the study.
